PCOS Management Challenges

Limitations of Current therapies

Reduction in GLP1 Expression

Lean and Obese PCOS Patients show 31% reduction in GLP1 expression.

High Visceral Adiposity Index

Indian PCO phenotype (Obese & Lean) have high Visceral Adiposity Index due to downregulation of UCP-1


Adherence

Studies show that 68% PCOS women struggle to adhere to their diet and exercise plan making PCOS management difficult.

Disclaimer: Above data / claim is based on the clinical evidence obtained from GLP-1 RA, UCP-1 and individual API molecules, Individual Results may vary*

ByzeptaTM is a diet and exercise mimetic pill for PCOS management by controlling insulin resistance and metabolic syndrome.

Quick Links

Contact Details

© Copyright 2025 Celagenex LLC. All Right Reserved. Website Designed by Enthof